In line with this hypothesis, pedigree studies of hypertension and LDL cholesterol [17], quantitative genetic estimates of dominance variance for blood pressure, LDL, fasting insulin and measures of lung function [18] and analysis of genome-wide heterozygosity using microsatellites [19] all suggest that numerous recessive variants contribute to complex disease risk. This evidence concerns the gene INS and Hypertension.